Valuation

Insurance/Reinsurance Valuation

Insurance/Reinsurance Valuation

Insurer and reinsurer valuation requires a thorough understanding of insurance accounting statements, loss reserving, asset valuation, capital requirements, and insurance contracts in addition to valuation expertise. In the case of a firm valuation, the valuation will include a strategic assessment of a firm’s ability to generate profit relative to others in the industry and an assessment of regulatory conditions. A valuation might be restricted to a single contract or portfolio of contracts where the focus would be primarily on the expected claims costs, the investment assets, and any additional contractual features. In addition to valuing insurance firms and contracts, NERA experts have also provided insurance buyers with estimates of the expected risk exposure.

NERA's insurance experts combine deep industry knowledge with expertise in valuation, economics, finance, and accounting to address insurer and reinsurer valuations. Our experts have experience working with insurer and reinsurer financial statements, regulatory filings, statutory accounting, and actuarial data.

Name Title Location Phone Email
Dr. Denise Neumann Martin Managing Director Miami +1 305 808 7880 denise.martin@nera.com
Dr. James Jordan Affiliated Consultant Washington, DC +1 202 466 9263 james.jordan.affiliate@nera.com
Title Type Author
Transfer Pricing Solutions for Intragroup Shared Services White Paper Dr. Niraja Srinivasan and Nihan Mert-Beydilli
‘Coca-Cola’ vs. Section 482: Is It Time to Refresh the Regulatory Guidance? Published Article Dr. Harlow Higinbotham and Dr. Niraja Srinivasan
Snapshot of Recent Trends in Asbestos Litigation 2021 Update Mary Elizabeth C. Stern and Lucy P. Allen
Going digital multinationals: Navigating economic and social imperatives in a post-pa... Published Article Niraja Srinivasan, et al.
NERA Experts Contribute Chapter to "The Future of the Profit Split Method" Book Dr. Harlow Higginbotham and Dr. Vladimir Starkov
Trends in Canadian Securities Class Actions: 2020 Update Report Bradley A. Heys, Robert Patton, and Jielei Mao
Transfer Pricing Roundtable in Financier Worldwide. Expert QA Dr. Vladimir Starkov and Philip de Homont
Amount B: Facts and Circumstances Matter—Even for Routine Distributors Published Article Dr. Harlow Higinbotham, Dr. Niraja Srinivasan, Dr. Vladimir Starkov, and Nihan Mert-Beydilli
Recent Trends in Securities Class Action Litigation: 2020 Full-Year Review Report Janeen McIntosh and Svetlana Starykh
NERA Experts Comment on the OECD Proposal on Pillar One Blueprint Brief Dr. Harlow Higinbotham, Dr. Vladimir Starkov, Dr. Niraja Srinivasan, Nihan Mert Beydilli, Ralph Meghames, and Dr. Emmanuel Llinares